RENAISSANCE PHARMA



Trademark Coverage

No Class Specified

Pharmaceutical products and devices, namely, Athletes' foot preparations; Bismuth preparations for pharmaceutical use; Pharmaceutical preparations for use in ocular disorders; Pharmaceutical preparations for use in oncology; Pharmaceutical preparations for use in ophthalmology; Pharmaceutical preparations for the relief of pain; Pharmaceutical preparations for the treatment of acne; Pharmaceutical preparations for the treatment of allergies; Pharmaceutical preparations for the treatment of bacterial skin infections, viral skin infections and parasitic skin infections; Pharmaceutical preparations for the treatment of blood disorders; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for the treatment of cardiovascular diseases; Pharmaceutical preparations for the treatment of carpal tunnel syndrome; Pharmaceutical preparations for the treatment of chronic pain; Pharmaceutical preparations for the treatment of dental and oral diseases; Pharmaceutical preparations for the treatment of diabetes; Pharmaceutical preparations for the treatment of diseases, disorders and infections of the endocrine system, namely, growth and thyroid disorders; Pharmaceutical preparations for the treatment of diseases, disorders and infections of the spinal cord systems and related cartilage and tissue; Pharmaceutical preparations for the treatment of drug and alcohol abuse; Pharmaceutical preparations for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the treatment of genitor-urinary and pelvic diseases, disorders and infections, namely, infertility, sexually transmitted diseases, incontinence and sexual dysfunction; Pharmaceutical preparations for the treatment of genitourinary diseases, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; Pharmaceutical preparations for the treatment of glaucoma; Pharmaceutical preparations for the treatment of headaches; Pharmaceutical preparations for the treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes; Pharmaceutical preparations for the treatment of infectious diseases, namely, respiratory infections, eye infections; Pharmaceutical preparations for the treatment of inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases; Pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely, diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia; Pharmaceutical preparations for the treatment of metabolic disorders, namely, diabetes, bulimia nervosa, anorexia, obesity and hypothyroidism; Pharmaceutical preparations for the treatment of migraine; Pharmaceutical preparations for the treatment of motion sickness; Pharmaceutical preparations for the treatment of myalgia and neuralgia; Pharmaceutical preparations for the treatment of neurological diseases, namely, Alzheimer's, Huntington's Disease, cerebral palsy; Pharmaceutical preparations for the treatment of neurological disorders, namely, brain injury, spinal cord injury, seizure disorders; Pharmaceutical preparations for the treatment of oncological diseases and disorders; Pharmaceutical preparations for the treatment of ophthalmological diseases and disorders; Pharmaceutical preparations for the treatment of physical and psychological addictions, namely, gambling addiction, eating disorders and addictions, nicotine addiction, Internet addiction, drug addiction; Pharmaceutical preparations for the treatment of psychiatric and other brain diseases and disorders, namely, anxiety, mood disorders, schizophrenia, cognitive and bipolar disorders, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, multiple sclerosis, seizures; Pharmaceutical preparations for the treatment of psychiatric diseases, namely, mood disorders, anxiety disorders, cognitive disorders, schizophrenia; Pharmaceutical preparations for the treatment of respiratory diseases, disorders and infections; Pharmaceutical preparations for the treatment of skin irritations, namely, bee stings, sunburn, rashes, sores, corns, calluses, and acne; Pharmaceutical preparations for the treatment of smoking cessation; Pharmaceutical preparations for the treatment of the central nervous system, namely, central nervous system, infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases; Pharmaceutical preparations for the treatment of the central nervous system, namely, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease; Pharmaceutical preparations for the treatment of the diseases, disorders and infections of the central nervous system, namely, brain, movement, ocular motility and spinal cord diseases; Pharmaceutical preparations for the treatment of the musculoskeletal system, namely, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries; Pharmaceutical preparations for the treatment of the respiratory system; Pharmaceutical preparations for the treatment of varicose veins; Pharmaceutical preparations for the treatment of vascular diseases; Pharmaceutical preparations for the treatment of viral diseases, namely, herpes, hepatitis, Acquired Immune Deficiency Syndrome (AIDS); Pharmaceutical preparations for use in dermatology, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases; Pharmaceutical preparations for use in gastroenterology; Thyroid hormonal preparations; Vaginal antifungal preparations

Owner

RENAISSANCE PHARMA INC.

Business in LONGUEUIL, CA

Owns 1 trademark

Timeline
  • Oct 15
    2013
    Registered Principal Register
  • Sep 07
    2013
    Notice Of Acceptance Of Statement Of Use E Mailed
  • Sep 06
    2013
    Law Office Registration Review Completed
  • Sep 06
    2013
    Allowed Principal Register SOU Accepted
  • Jul 30
    2013
    Statement Of Use Processing Complete
  • Jul 04
    2013
    Use Amendment Filed
  • Jul 26
    2013
    Case Assigned To Intent To Use Paralegal
  • Jul 04
    2013
    TEAS Statement Of Use Received
  • May 21
    2013
    NOA E Mailed SOU Required From Applicant
  • Mar 26
    2013
    Official Gazette Publication Confirmation E Mailed
  • Mar 26
    2013
    Published For Opposition
  • Mar 06
    2013
    Notification Of Notice Of Publication E Mailed
  • Feb 21
    2013
    Law Office Publication Review Completed
  • Feb 21
    2013
    Assigned To LIE
  • Feb 06
    2013
    Approved For PUB Principal Register
  • Feb 06
    2013
    Examiner's Amendment Entered
  • Feb 06
    2013
    Notification Of Examiners Amendment E Mailed
  • Feb 06
    2013
    Examiners Amendment E Mailed
  • Feb 06
    2013
    Examiners Amendment Written
  • Feb 06
    2013
    Notification Of Non Final Action E Mailed
  • Feb 06
    2013
    Non Final Action E Mailed
  • Feb 06
    2013
    Non Final Action Written
  • Jan 30
    2013
    Assigned To Examiner
  • Oct 10
    2012
    Notice Of Design Search Code Mailed
  • Oct 09
    2012
    New Application Office Supplied Data Entered In TRAM